Chiesi Farmaceutici originated in Parma in 1935 as a pharmacy. Today, we are an international company based in Parma, with 80 years of experience and a strong focus on research, development, production and the commercialisation of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas. With a turnover of more than ó1.4 billion sales we are among the top 50 pharmaceutical companies in the world. Our production sites are in Parma, Italy, Blois (France) and Santana De Parnaiba (Brazil). The R&D centres in Parma (Italy), Paris (France), Cary (USA), Chippenham (UK) and the R&D team from the acquired Danish company Zymenex, integrate their efforts to advance Chiesi's pre-clinical, clinical and registration programmes. We export to more than 70 countries with a direct presence in 26. The Chiesi Group employs approximately 4,500 people, 560 of whom are dedicated to R&D activities and 700 of whom work at production sites.